MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)
- Previous Close
6.490 - Open
6.500 - Bid 6.360 x --
- Ask 6.500 x --
- Day's Range
6.310 - 6.650 - 52 Week Range
3.120 - 6.920 - Volume
38,800 - Avg. Volume
130,188 - Market Cap (intraday)
2.662B - Beta (5Y Monthly) 0.45
- PE Ratio (TTM)
-- - EPS (TTM)
-0.160 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.53
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and sale of diabetes management, diabetes treatment, and diabetes monitoring medical devices to diabetes management in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; and diabetes digital management software. It is also involved in scientific research and technical services; business services; wholesale and retail; manufacturing; and commercials. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.
www.microtechmd.comRecent News: 2235.HK
View MorePerformance Overview: 2235.HK
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2235.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2235.HK
View MoreValuation Measures
Market Cap
2.66B
Enterprise Value
832.80M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.27
Price/Book (mrq)
1.26
Enterprise Value/Revenue
2.28
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-18.26%
Return on Assets (ttm)
-4.28%
Return on Equity (ttm)
-3.13%
Revenue (ttm)
345.62M
Net Income Avi to Common (ttm)
-63.12M
Diluted EPS (ttm)
-0.160
Balance Sheet and Cash Flow
Total Cash (mrq)
1.71B
Total Debt/Equity (mrq)
0.01%
Levered Free Cash Flow (ttm)
-150.84M